Instrument Inactif

Communiqués OrganiGram Holdings Inc Toronto S.E.

Actions

CA68620P1018

Installations et services en soins de santé

Communiqués

20/08	Organigram Global accélère l’intégration de Sanity Group au sein d’une structure opérationnelle mondiale unifiée	BU
20/08	Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure	BU
12/08	European acquisition powers cannabis company Organigram to record revenues	AQ
12/08	Organigram annonce des résultats records pour le troisième trimestre de l’exercice 2026	BU
11/08	OrganiGram: Fiscal Q3 Earnings Snapshot	AQ
11/08	Organigram Global : Press Release (dad9ab 3b3eb18f)	PU
11/08	Organigram Reports Record Third Quarter Fiscal 2026 Results	BU
04/08	Organigram to Report Third Quarter Fiscal 2026 Results on August 11, 2026	BU
20/07	Organigram Provides Business Update Highlighting Initial Sanity Performance and Canadian Market Share	BU
12/05	Organigram Global : INVESTOR PRESENTATION (dad9ab a7f6d4c8)	PU
12/05	OrganiGram: Fiscal Q2 Earnings Snapshot	AQ
12/05	Organigram Global : Press Release (dad9ab a96f5298)	PU
12/05	Organigram Reports Second Quarter Fiscal 2026 Results	BU
06/05	Organigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026	BU
15/04	Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities	BU
31/03	Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting	BU
23/03	Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH	BU
10/03	Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting	BU
06/03	Organigram Global Expands FAST Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity	AQ
05/03	Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity	BU
24/02	Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia	BU
19/02	Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group	BU
18/02	Organigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis Company	BU
10/02	Organigram Global : INVESTOR PRESENTATION (25288d 0a40b503)	PU
10/02	Organigram Global : Financial Statements (25288d 48daff1f)	PU